Cite
HARVARD Citation
Holz, F. et al. (2022). A CONSENSUS ON RISK MITIGATION FOR BROLUCIZUMAB IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION. Retina. 42 (9), pp. 1629-1637. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Holz, F. et al. (2022). A CONSENSUS ON RISK MITIGATION FOR BROLUCIZUMAB IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION. Retina. 42 (9), pp. 1629-1637. [Online].